Journal article
Calcitonin for preventing and treating corticosteroid‐induced osteoporosis
Abstract
BACKGROUND: Corticosteroid-induced osteoporosis is a cause of morbidity in patients with chronic obstructive lung disease, asthma, and rheumatologic disorders. Corticosteroid treatment causes bone loss by a variety of complex mechanisms. It has been shown that bone mineral loss at the hip averages 14% in the first year after starting corticosteroid therapy.
OBJECTIVES: To review the efficacy of calcitonin (subcutaneous or nasal) for the …
Authors
Cranney A; Welch V; Adachi J; Homik J; Shea B; Suarez‐Almazor ME; Tugwell P; Wells GA
Journal
Cochrane Database of Systematic Reviews, Vol. 2010, No. 1,
Publisher
Wiley
Publication Date
2000
DOI
10.1002/14651858.cd001983
ISSN
1361-6137